Abstract |
To avoid major bleeding events in warfarin and S-1 combination therapy, PT-INR levels should be monitored frequently to allow for precise adjustments of the warfarin dose and to verify any side effects reported by the patient. We therefore developed a support system where outpatients obtain a home-measured PT-INR value using the CoaguChek(®) system and submit it along with details of any side effects to us via the Internet using their mobile phone. A 59-year-old man was started on warfarin (1.5 mg/d) and S-1 (100 mg/d), a combination preparation of tegafur, gimeracil, and oteracil potassium, to treat cholangiocarcinoma. The patient sent his data to the hospital pharmacist every two days after starting S-1 therapy. When the PT-INR was outside the target range of 1.5-2.7, the pharmacist, after consulting the physician, instructed the patient to change his warfarin dose by 0.5 mg. On day 24 after starting S-1, PT-INR had increased from 1.6 to 2.8, so the dose was decreased by 0.5 mg. Thereafter, the dose was adjusted by 0.5-1.0 mg during the observation period so that the patient was able to maintain the therapeutic range approximately 90% of the time. We anticipate this system can be applied to S-1 which interact with warfarin, thereby enabling safer anticoagulation therapy.
|
Authors | Keiko Yamamura, Koji Yano, Yoshiki Hirooka, Akihiro Hirashiki, Toyoaki Murohara, Kiyofumi Yamada |
Journal | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
(Yakugaku Zasshi)
Vol. 135
Issue 7
Pg. 925-7
( 2015)
ISSN: 1347-5231 [Electronic] Japan |
PMID | 25913669
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Drug Combinations
- S 1 (combination)
- Tegafur
- Warfarin
- Oxonic Acid
|
Topics |
- Cholangiocarcinoma
(drug therapy)
- Drug Combinations
- Drug Interactions
- Drug Therapy, Combination
- Drug-Related Side Effects and Adverse Reactions
(prevention & control)
- Humans
- International Normalized Ratio
(methods)
- Internet
- Male
- Middle Aged
- Monitoring, Physiologic
(methods)
- Oxonic Acid
(administration & dosage, adverse effects)
- Prothrombin Time
- Tegafur
(administration & dosage, adverse effects)
- Warfarin
(administration & dosage, adverse effects)
|